Adam earned his MBA from Babson College and initially pursued a career in advertising with Young and Rubicam in New York, later expanding his experience in Moscow. Upon returning to the U.S., Adam transitioned to biotechnology, co-founding Alpha Biopartners in 2005. His interest in the therapeutic potential of curcumin led him to develop a novel absorption technology, which became the cornerstone of his current venture, UltraBotanica, LLC.
This platform technology not only enhanced the bioavailability of curcumin but also laid the groundwork for broader applications in plant bioactives. Under Adam&#8217;s leadership, UltraBotanica has become a pioneer in leveraging this technology to improve the efficacy of natural products, significantly impacting health and wellness. His innovative approach has driven breakthrough results in the field, transforming the use of natural compounds in therapeutic applications.
Over the past 20 years, Adam’s contributions to biotech have centered on developing effective, natural-based health solutions. His work has consistently pushed the boundaries of biotechnological innovation, ensuring that UltraBotanica remains at the forefront of the industry. Through his efforts, Adam has profoundly influenced both the market and the lives of many, underscoring his commitment to advancing health through biotech innovations.

Adam Payne, MBA